CN107789610A - One kind treats dermopathic ointment - Google Patents
One kind treats dermopathic ointment Download PDFInfo
- Publication number
- CN107789610A CN107789610A CN201711422273.5A CN201711422273A CN107789610A CN 107789610 A CN107789610 A CN 107789610A CN 201711422273 A CN201711422273 A CN 201711422273A CN 107789610 A CN107789610 A CN 107789610A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- sulphur
- kapur
- flavones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses one kind to treat dermopathic ointment, and the ointment is made up by weight of following component:5~9 parts of kapur, 20~30 parts of flavones, 10~20 parts of realgar, 30~40 parts of benzoic acid, 50~60 parts of salicylic acid, 40~50 parts of sulphur, 10~15 parts of green vitriol, 20~30 parts of pumpkin seeds, 5~6 parts of ginger splices, 50~60 parts of vaseline, the ointment need 150 parts of alcohol mixing mentioned components to be formulated.The present invention is external used medicine, have promoting blood circulation, sterilization, it is antipruritic, except moss, dispel the effect such as eczema, can effectively treat all kinds of disease of skin such as acne, eczema, brothers moss, and have no side effect, reduce the possibility of sufferer recurrence.
Description
Technical field
The present invention relates to pharmaceutical sanitary field, in particular to one kind to treat dermopathic ointment.
Background technology
Skin disease is very common disease, and the traditional Chinese medical science thinks that it is that vivotoxin is accumulated too to cause dermopathic main cause
It is more, cause the function of detoxification of liver and the functions of expelling toxin of kidney to can't bear load, finally itched via skin, play measles, be whelk, rotten
The approach such as sore, nameless sores or boils, discharge internal toxin.But if internal toxin, it can not one by one be excluded, finally had for a long time
Chronic eczema the most serious in skin disease may be developed into.
At present, the dermopathic medicine of the treatment of commercial type, the effect of alleviation can only be played after medication, but after being discontinued
Acne, eczema, brothers moss still have the situation of recurrence, while have some potential side effects, some malignant dermatologics, not
To effectively treating, entail dangers to patient vitals.
The content of the invention
The purpose of the present invention is exactly to solve the above problems, there is provided one kind treats dermopathic ointment, its have promoting blood circulation,
Sterilization, it is antipruritic, except moss, dispel the effect such as eczema, curative effect is good, the features such as having no toxic side effect.
The present invention is realizes object above, using following scheme:
One kind treats dermopathic ointment, and the ointment is made up by weight of following component:5~9 parts of kapur, flavones 20~
30 parts, 10~20 parts of realgar, 30~40 parts of benzoic acid, 50~60 parts of salicylic acid, 40~50 parts of sulphur, 10~15 parts of green vitriol, south
20~30 parts of melon seeds, 5~6 parts of ginger splices, 50~60 parts of vaseline.
Preferably, the ointment needs 150 parts of alcohol mixing mentioned components to be formulated.
Preferably, the ointment preparation method comprises the following steps:
A. 5~9 parts of kapur, 20~30 parts of flavones, 10~20 parts of realgar, 30~40 parts of benzoic acid, 50~60 parts of salicylic acid,
40~50 parts of sulphur, 10~15 parts of green vitriol, 20~30 parts of pumpkin seeds, 5~6 parts of ginger splices, 50~60 parts of vaseline are crushed, are screened into
Medicinal powder;
B. above-mentioned medicinal powder is added into 150 parts of alcohol, is mixed evenly, is settled into paste.
Preferably, occupation mode is that ointment is applied into affected part.
In the present invention:Kapur has the effect of inducing resuscitation of having one's ideas straightened out, available for clearing away heat to and alleviating pain, erosion prevention and muscle growing;Flavones has eliminating the phlegm, disappeared
Product, the function of analgesic, external application can control mange;Realgar has convergence local mucous membrane blood vessel, protects ulcer surface and reduces mucous secretion
Effect;Benzoic acid is combined with salicylic acid, can suppress dermatomycosis, mycotic infection of superficial part;Sulphur produces sulphur with skin contact
Changing hydrogen plays the role of killing fungus, kills mange;Green vitriol is eliminating dampness and eliminating phlegm, and disperse accumulations desinsection, hemostasis is enriched blood, removing toxic substances sore, cures mainly yellow swelling
It is full, infantile malnutrition due to digestive disturbances or intestinalparasites protracted dysentery, hematochezia, blood deficiency chlorosis, wet sore mange;Ginger splices have orifice opening, qi stagnation removing, ward off foul, desinsection is antipruritic,
The effect of swelling and pain relieving, cure mainly mange itch;Vaseline can keep the moistening of skin.
The beneficial effects of the invention are as follows:
1st, it is of the invention compared with the existing dermopathic Chinese medicine for the treatment of, it can effectively treat whelk, measles, rotten sore, dry moss.
2nd, the present invention have it is green, materials it is pure natural, have no toxic side effect, illness does not recur feature.
Embodiment
Illustrate the manufacturing process of the present invention below by way of specific embodiment:
Within the scope of the invention or do not departing from present disclosure, in spirit and scope, the change that is carried out to the present invention,
Combination is replaced, and will be apparent to the person skilled in the art, and be included within the scope of the present invention.
Embodiment 1:
One kind treats dermopathic ointment, and the ointment is made up by weight of following component:7 parts of kapur, 25 parts of flavones, hero
Yellow 15 parts, 35 parts of benzoic acid, 52 parts of salicylic acid, 45 parts of sulphur, 12 parts of green vitriol, 23 parts of pumpkin seeds, 6 parts of ginger splices, 53 parts of vaseline,
The ointment needs 150 parts of alcohol mixing mentioned components to be formulated.
The ointment preparation method comprises the following steps:
A. 7 parts of kapur, 25 parts of flavones, 15 parts of realgar, 35 parts of benzoic acid, 52 parts of salicylic acid, 45 parts of sulphur, 12 parts of green vitriol,
23 parts of pumpkin seeds, 6 parts of ginger splices, 53 parts of vaseline crush, are screened into medicinal powder;
B. above-mentioned medicinal powder is added into 150 parts of alcohol, is mixed evenly, is settled into paste.
In preparation process, gnotobasis should be kept, all tools vessel all answer strict sterilization.
Embodiment 2:
One kind treats dermopathic ointment, and the ointment is made up by weight of following component:5 parts of kapur, 20 parts of flavones, hero
Yellow 10 parts, 30 parts of benzoic acid, 50 parts of salicylic acid, 40 parts of sulphur, 10 parts of green vitriol, 20 parts of pumpkin seeds, 5 parts of ginger splices, 50 parts of vaseline,
The ointment needs 150 parts of alcohol mixing mentioned components to be formulated.
The ointment preparation method comprises the following steps:
A. 5 parts of kapur, 20 parts of flavones, 10 parts of realgar, 30 parts of benzoic acid, 50 parts of salicylic acid, 40 parts of sulphur, 10 parts of green vitriol, south
20 parts of melon seeds, 5 parts of ginger splices, 50 parts of vaseline crush, are screened into medicinal powder;
B. above-mentioned medicinal powder is added into 150 parts of alcohol, is mixed evenly, is settled into paste.
In preparation process, gnotobasis should be kept, all tools vessel all answer strict sterilization.
The present invention is external used medicine, please don't be eaten, and such as imprudence enters eyes, is please rinsed immediately using clear water, and sees a doctor,
It is application method below:
It will first be rinsed well at sufferer using clear water, further take out ointment of the present invention, be uniformly applied to surface at sufferer, in the morning, afternoon and evening one
It applies smear primary effect more three times, before sleep again;Before smearing every time, it will need to be cleaned at sufferer totally, after sufferer recovery from illness
It is discontinued.
The present invention is confirmed by 500 clinical tests, and cure rate reaches 98%, had no adverse reaction, and does not have recurrence case after drug withdrawal
Example, is below clinical test case and data:
Zhang Lifeng, man, 18 years old, Shandong people from Yantai, be after diagnosing skin eczema, and with symptoms such as itch, uses certain brand skin
Scorching cream, is not cured, there is rebound phenomenon, is smeared affected part using ointment of the present invention, without pruritis after 10 days, is fully recovered after 14 days.
Wang Tianbing, female, 40 years old, Sanya, Hainan people, face suffered from rotten sore, obstinate, and had routed purulence symptom, used this hair
Bright ointment smears affected part, and useless fellow eliminates after 10 days, and rotten sore is fully recovered after 16 days, does not leave dark scar.
Li Keqian, female, 16 years old, Anhui people from Dangshan, face suffered from whelk, smears ointment of the present invention, and whelk presses down after 5 days
System growth, acne print disappears after 10 days, and being discontinued 15 days does not have rebound phenomenon.
Cui He, man, 28 years old, Ya'an Sichuan province people, throughout the year with sufficient moss illness, using a variety for the treatment of methods, is not controlled thoroughly
More illness, persistently using this ointment 1 month, sufficient moss symptom substantially mitigates, and adheres to using 2 months on the original basis, sufficient moss disease
Shape disappears, and is not recurred after being discontinued 1 month.
1st, criterion of therapeutical effect
Recovery from illness:Symptom all disappears, and does not recur.
Effectively:Symptom disappears substantially, leaves dark trace.
It is invalid:Symptom is not improved.
2nd, efficacy result statistical form:
Project | Number | Average age | Recovery from illness number | Efficiently individual quantity | Invalid number | Treatment rate |
Man | 250 people | 32 | 245 people | 2 | 3 | 98.8% |
Female | 250 people | 41 | 243 people | 5 | 2 | 99.2% |
Above table illustrates the dermopathic ointment of the treatment to treating skin disease positive effect.
Although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with
Understand on the basis of the principle of the present invention and spirit is not departed from, these embodiments can be carried out with a variety of changes, modification, replaced
And modification, without departure from protection scope of the present invention, limited by the claim and its equivalent.
Claims (4)
1. one kind treats dermopathic ointment, it is characterised in that the ointment is made up by weight of following component:Kapur 5
~9 parts, it is 20~30 parts of flavones, 10~20 parts of realgar, 30~40 parts of benzoic acid, 50~60 parts of salicylic acid, 40~50 parts of sulphur, green
10~15 parts of alum, 20~30 parts of pumpkin seeds, 5~6 parts of ginger splices, 50~60 parts of vaseline.
2. one kind according to claim 1 treats dermopathic ointment, it is characterised in that the ointment needs 150 parts of alcohol
Mixing mentioned component is formulated.
3. one kind according to claim 2 treats dermopathic ointment, it is characterised in that the ointment preparation method includes
Following steps:
A, 5~9 parts of kapur, 20~30 parts of flavones, 10~20 parts of realgar, 30~40 parts of benzoic acid, 50~60 parts of salicylic acid,
40~50 parts of sulphur, 10~15 parts of green vitriol, 20~30 parts of pumpkin seeds, 5~6 parts of ginger splices, 50~60 parts of vaseline are crushed, are screened into
Medicinal powder;
B, above-mentioned medicinal powder is added into 150 parts of alcohol, is mixed evenly, is settled into paste.
4. one kind according to claim 1 treats dermopathic ointment, it is characterised in that occupation mode is to smear ointment
In affected part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711422273.5A CN107789610A (en) | 2017-12-25 | 2017-12-25 | One kind treats dermopathic ointment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711422273.5A CN107789610A (en) | 2017-12-25 | 2017-12-25 | One kind treats dermopathic ointment |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107789610A true CN107789610A (en) | 2018-03-13 |
Family
ID=61537722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711422273.5A Pending CN107789610A (en) | 2017-12-25 | 2017-12-25 | One kind treats dermopathic ointment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107789610A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224033A (en) * | 2018-10-23 | 2019-01-18 | 陈晋广 | It is a kind of to treat dermopathic ointment and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435225A (en) * | 2002-12-24 | 2003-08-13 | 黄宝田 | Medical ointment Jiaoxuanxiao for treating beriberi |
CN107320519A (en) * | 2017-08-29 | 2017-11-07 | 王红芝 | One kind treats dermopathic ointment |
-
2017
- 2017-12-25 CN CN201711422273.5A patent/CN107789610A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435225A (en) * | 2002-12-24 | 2003-08-13 | 黄宝田 | Medical ointment Jiaoxuanxiao for treating beriberi |
CN107320519A (en) * | 2017-08-29 | 2017-11-07 | 王红芝 | One kind treats dermopathic ointment |
Non-Patent Citations (1)
Title |
---|
大丹增: "《中国藏药材大全》", 30 April 2016, 中国藏学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224033A (en) * | 2018-10-23 | 2019-01-18 | 陈晋广 | It is a kind of to treat dermopathic ointment and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101019948A (en) | Acne treating compound Chinese medicine prepn | |
CN102125634A (en) | Chinese medicinal composition for treating bedsore | |
CN108653479A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating refractory skin | |
CN107320519A (en) | One kind treats dermopathic ointment | |
CN108245602B (en) | A topical Chinese medicinal composition for treating dermatoses | |
CN107789610A (en) | One kind treats dermopathic ointment | |
CN109674945A (en) | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic | |
CN111821373B (en) | Traditional Chinese medicine hydrogel external application patch for treating phlebitis | |
CN110339231B (en) | Traditional Chinese medicine composition for treating allergic dermatitis and preparation method thereof | |
CN114404502A (en) | Traditional Chinese medicine composition for treating allergic rhinitis and chronic rhinitis and preparation method | |
CN112972578A (en) | Ointment for treating psoriasis and preparation method thereof | |
CN111544514A (en) | A Chinese medicinal ointment for treating burn and scald, and its preparation method | |
CN104306859A (en) | Ointment for treating erosive beriberi and preparing method thereof | |
CN108066466A (en) | A kind of Chinese medicine composition for treating burn and scald and preparation method and application | |
CN113332365B (en) | Compound lithospermum ointment and preparation method thereof | |
CN103784801A (en) | Traditional Chinese medicinal externally-applied preparation for treating face dermatitis | |
CN103977107B (en) | One treats leukodermic Chinese medicine composition | |
CN103933426B (en) | A kind for the treatment of skin disease external preparation, preparation and application | |
CN116211923B (en) | Traditional Chinese medicine medicated bath preparation for treating tinea, and preparation method and application thereof | |
CN102920800A (en) | Topical drug composite and application and preparation method thereof | |
CN103720728A (en) | Medicine for curing beriberi | |
CN101658583B (en) | Traditional Chinese medicine for treating cold-dampness type skin ulcer and preparation method thereof | |
CN104958358A (en) | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof | |
CN115252746A (en) | Traditional Chinese medicine for treating phlebitis, traditional Chinese medicine dressing prepared from traditional Chinese medicine and adhesive plaster | |
CN115624592A (en) | Lotion for eliminating dampness and healing sores and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180313 |
|
RJ01 | Rejection of invention patent application after publication |